XML 63 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock
3 Months Ended
Dec. 31, 2013
Common Stock [Abstract]  
Common Stock
11.
Common Stock
 
Effective on November 23, 2012, the Company completed a private placement for an aggregate of 42,857,142 units at a price of $0.07 per unit for an aggregate of $3,000,000 (including a deposit received prior to September 30, 2012 of $300,000). Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at a price of $0.105 per common share for a period of three years from the date of closing, provided that if the closing price of the common shares of the Company on the principal market on which the shares trade is equal to or exceeds $1.00 for 30 consecutive trading days, the warrant term shall automatically accelerate to the date which is 30 calendar days following the date that written notice has been given to the warrant holders. The warrants expire on November 23, 2015. The value of the common shares and the warrants totaled $1,985,249 and $1,014,751, respectively.
 
On June 20, 2013, the Company completed a private placement for an aggregate of 850,000 units at a price of $0.05 per unit for an aggregate of $42,500. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at a price of $0.075 per common share for a period of three years from the date of closing, provided that if the closing price of the common shares of the Company on the principal market on which the shares trade is equal to or exceeds $1.00 for 30 consecutive trading days, the warrant term shall automatically accelerate to the date which is 30 calendar days following the date that written notice has been given to the warrant holders. The warrants expire on June 20, 2016. The value of the common shares and the warrants totaled $27,448 and $15,052, respectively.
 
On July 31, 2013, the Company completed a private placement for an aggregate of 45,111,778 common shares for an aggregate of $22,000,000. Pursuant to the subscription agreement between the Company and investor the Company issued the shares to the investor after September 20, 2013 but before November 30, 2013. No warrants were issued to the investor in connection with this private placement.
 
Between August 12 and August 15, 2013, six directors and two consultants of the Company acquired a combined total of 3,768,096 common shares, upon exercising stock options and warrants, at exercise prices ranging from $0.05 to $0.14 per common share for total combined gross proceeds to the Company of $372,000.
 
Return of Capital Distribution
 
On August 9, 2013, the Company approved a distribution to its shareholders in the amount of $0.07 per share to be payable on September 20, 2013 (the “Payment Date”) to the holders of record of all the issued and outstanding shares of common stock of the Company as of the close of business on August 16, 2013, (the “Record Date”). This cash distribution to the Company’s shareholders was not a dividend paid out of the earnings and profits, but was a non-dividend distribution characterized as a “return of capital”.
 
Warrants
 
On October 31, 2011, 14,500,000 warrants previously granted on October 31, 2008 expired unexercised.
 
On June 22, 2012, 1,000,000 warrants previously granted on June 22, 2007 expired unexercised.
 
On July 11, 2012, 38,800 warrants previously granted on July 11, 2007 expired unexercised.
 
On October 10, 2013, the Company extended the expiration date of two warrants to purchase up to an aggregate of 29,047,617 shares of the Company’s common stock. The exercise price of the warrants remains unchanged at $0.105 per share. As a result of this extension, the expiration date of the warrants has been amended from the original expiry date of November 9, 2013 to November 23, 2015.
 
The following table summarizes the Company’s warrants outstanding as of December 31, 2013:
 
   
Shares Underlying
Warrants Outstanding
   
Shares Underlying
Warrants Exercisable
 
Range of Exercise Price
 
Shares Underlying Warrants Outstanding
   
Weighted Average Remaining Contractual Life
   
Weighted Average Exercise Price
   
Shares Underlying Warrants Exercisable
   
Weighted Average Exercise Price
 
                               
$0.105 at December 31, 2013
    71,904,759       1.90       0.105       71,904,759       0.105  
$0.075 at December 31, 2013
    520,000       2.47       0.075       520,000       0.075  
      72,424,759       1.90       0.105       72,424,759       0.105  
 
The following is a summary of warrant activity for the period ended December 31, 2013:
 
   
Number of Warrants
   
Weighted Average Exercise Price
   
Intrinsic Value
 
                   
Balance, September 30, 2013
    72,424,759     $ 0.105     $ 0.195  
Granted
                 
Exercised
                 
Balance, December 31, 2013
    72,424,759     $ 0.105     $ 0.335  
                         
Outstanding Warrants, December 31, 2013
    72,424,759     $ 0.105     $ 0.335  
 
There were 72,424,759 warrants outstanding as of December 31, 2013 (September 30, 2013 – 72,424,759), which have a historical fair market value of $1,743,336 (September 30, 2013 - $1,743,336).
 
Measurement Uncertainty for Warrants
 
The Company used the Black-Scholes option pricing model (“Black-Scholes”) to value the options and warrants. This model was developed for use in estimating the fair value of traded “European” options which are liquid and that have no vesting restrictions and are fully transferable. Stock options and the warrants attached to the units issued by the Company are non-transferable and vest over time, and are “American” options. Option pricing models require the input of subjective assumptions including expected share price volatility. The fair value estimate can vary materially as a result of changes in the assumptions. The following assumptions are used in the Black-Scholes option-pricing model:
 
Expected Term – Expected term of 5 years represents the period that the Company’s stock-based awards are expected to be outstanding.
 
Expected Volatility – Expected volatilities are based on historical volatility of the Company’s stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. The expected volatility used ranged from 96% to 116%.
 
Expected Dividend – The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company currently pays no dividends and does not expect to pay dividends in the foreseeable future.
 
Risk-Free Interest rate – The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. The risk-free rate used ranged from 0.62% to 1.31%.
 
On June 20, 2013, the Company completed a private placement for an aggregate of 850,000 units at a price of $0.05 per unit for an aggregate of $42,500. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at a price of $0.075 per common share for a period of three years from the date of closing, provided that if the closing price of the common shares of the Company on the principal market on which the shares trade is equal to or exceeds $1.00 for 30 consecutive trading days, the warrant term shall automatically accelerate to the date which is 30 calendar days following the date that written notice has been given to the warrant holders. The warrants expire on June 20, 2016. The value of the common shares and the warrants totaled $27,448 and $15,052, respectively.